Linc AB
Update in progressLINC.ST (Stockholm)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorFinancial Services
- IndustryAsset Management
Linc AB is a private equity and venture capital firm focused on pharma, life science, and medical technology. It backs both early and mature stage ventures, with early drug development often pursued in earlier rounds and more mature medical tech in later rounds. Investments span private, public, research, and operational entities, with a Nordic focus. Typical checks range from SEK 25 million to 250 million, often with a small initial stake and larger follow-ons. Founded 1991, Stockholm.
Company score
- Sentiment
- 0.33
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.06
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.13
- Governance
- 0.12
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.21
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!